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 RNA silencing is a broad term that has been 
used to describe RNA interference (RNAi) in 
animals, posttranscriptional gene silencing in 
plants, and quelling in fungi, which are all 
phenotypically different but mechanistically 
similar forms of RNAi 
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 RNAi is a natural process in which double-
stranded RNA (dsRNA) or hairpin RNA is 
cleaved by RNaseIII-type enzyme called Dicer 
into small interfering RNA (siRNA) duplex of 
21–26 nucleotides, which then direct 
sequence-specific, homology-dependent, 
posttranscriptional gene silencing by binding 
to its complementary RNA and triggering its 
elimination through degradation or by 
inducing translational inhibition 
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 RNAi is a natural process of gene silencing 
that occurs in many organisms ranging from 
plants to mammals. 
  RNAi was observed first by a plant scientist 
in the late 1980s, but the molecular basis of 
its mechanism remained unknown until the 
late 1990s, when research using the C. 
elegans nematode showed that RNAi is an 
evolutionarily conserved gene-silencing 
mechanism 
8 
 Sequence specific posttranscriptional RNAi 
gene silencing by doublestranded RNA is 
conserved in a wide range of organisms: 
plants (Neurospora), insect (Drosophila), 
nematodes (C. elegans), and mammals. 
 
  This process is part of the normal defense 
mechanism against viruses and the 
mobilization of transposable genetic 
elements 
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 To protect themselves from viral infections, cells have evolved several 
mechanisms. 
 In mammalian cells, virus-specific dsRNA induce the IFN pathway via the 
Toll-like receptor family or via a replication-dependent pathway involving 
the cytoplasmic dsRNA sensors retinoic-acid-inducible protein-1/ 
melanoma–differentiation-associated gene 5 (RIG-1/MD5). 
  Antiviral proteins that are induced by dsRNA also include the 2¢-5¢ 
oligoadenylate cyclase (2¢-5¢OAS)/RNAseL/PKR. 
  As RNAi, IFN responses, and 2¢-5¢OAS)/RNAseL/PKR are initiated by 
dsRNA, it is most likely these pathways work together in the antiviral 
innate immune response. Because the helicase RIG-1/MDA5 pathway can 
be stimulated by siRNA, these proteins could link antiviral RNAi and IFN 
responses 
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   siRNAs are 19-21 nucleotides 
long duplexes which are 
produced from ds RNAs (double 
stranded RNAs) by the action of 
an enzyme RNase III Dicer as 
shown in Figure1. These siRNA 
duplexes consist of a sense 
strand and a complementary 
anti-sense strand with a 
phosphate group at both the 
5’ends along with hydroxyl 
groups as well as two nucleotide 
overhangs at the 3’ends. The 
siRNAs unwind due to helicase 
activity of the RISC assembly 
after which the anti-sense strand 
attaches to the RISC and targets 
the specific mRNA  
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   Short hairpin RNAs (shRNAs) are a group 
of siRNAs which can be expressed with 
the use of U6 or H1 promoters 
(Brummelkamp et al., 2002a; Paul et al., 
2002). Sh RNAs have a plethora of 
advantages when compared to siRNAs like 
long time silencing effects as well as 
efficient and easy delivery methods. 
These shRNAs contain a single stranded 
RNA molecule of about 50-100 bases. The 
complementary regions are spaced with 
the help of a hairpin loop which allows 
the transcript to fold back on itself 
thereby getting the name “short hairpin” 
RNA. This shRNA is processed by Dicer and 
gets converted to siRNAs which unwind 
due to helicase activity of the RISC 
assembly after which the anti-sense 
strand gets incorporated into the RISC 
which cleaves the target mRNA due to its 
endonuclease activity  
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 The microRNAs (miRNAs) are another group of RNAi inducers that play an 
important role in development of an organism. They form an integral part 
as an endogenous gene silencing machinery as seen in Figure 1. The 
primary precursors of miRNAs which are referred to as primary miRNAs 
(pri-miRNAs) are present in the genome and get transcribed by RNA pol II 
(Kim, 2005). The pri-miRNAs consists of 33 base stem-loop structures in 
which the miRNA is present in the 5’ or 3’end of the stem. These pri-
miRNAs get processed by Drosha an RNAse III enzyme , which cleaves the 
pri-miRNAs to form 70 nucleotide long precursor miRNAs (pre-miRNAs), 
which get transported from the nucleus into the cytoplasm with the help 
of a protein called Exportin-5. These pre-miRNAs get cleaved in the 
cytoplasm by Dicer to form functional miRNAs which are about 21-25 
nucleotides in length. Further processing allows the antisense strand of 
the miRNA to get incorporated to the RISC assembly and leads to 
translational repression of the target mRNA (Zeng et al., 2005). MiRNAs 
play a major role in proliferation as well as apoptosis (Cheng et al., 
2005). MiRNAs are also found to regulate a number of oncogenes and 
tumour suppressor genes.  
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 The most important criteria for the success 
of RNAi based strategy depends on the 
efficient delivery of these biomolecules into 
the specific cell, tissue or organ. In vitro 
delivery of siRNAs is brought about using 
cationic liposome based methods whereas 
the same strategy cannot be successfully 
incorporated for in vivo delivery due to 
rapid clearance of these lipid molecules in 
the Liver.  
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 A number of successful in vivo delivery 
methods have been devised like combining 
siRNAs to antibody protamine fusion (Song et 
al., 2005),using the sense strand of the siRNA 
in combination with Cholesterol conjugate 
(Soutschek et al., 2004), incorporating 
siRNAs into cyclodextrin nanoparticles (Hu-
Lieskovan et al., 2005) as well as using 
aptamer siRNA conjugates (McNamara et al., 
2006). Each of these combinations can be 
used to bring about successful in vivo 
delivery of siRNA biomolecules targeting 
specific genes.  
17 
 Short hairpin RNAs (shRNAs) containing DNA-based 
expressed expression cassettes containing a sense 
and anti-sense strand along with Pol III promoters can 
also be successfully used as RNAi inducers 
(Brummelkamp et al., 2002a; Lee et al., 2002; 
Paddison et al., 2002; Sui et al., 2002).  
 Vector-based shRNA systems can be successfully 
delivered using viral vectors. Adenovirus and Adeno 
associated viral vectors (AAV) provide an excellent 
platform for delivery of shRNAs (Li et al., 2005a; 
Osada et al., 2005; Ragozin et al., 2005). Retroviral 
vectors like MLV(Murine leukemia Virus) (Hemann et 
al., 2003) and lentiviral vectors like HIV (Human 
Immunodeficiency Virus), FIV (Feline 
Immunodeficiency Virus), EIAV (Equine infectious 
anemia virus) have also been successfully used to 
deliver shRNAs to induce RNA interference (Dittgen et 
al., 2004; Bahi et al., 2005).  
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 RNAi has emerged as a potent method to 
bring about gene silencing and can be used 
as a therapeutic tool to treat many diseases 
(Hosono et al., 2005). In majority of cancers 
RNAi can be used to specifically target 
mutant genes, cancer associated genes, 
receptors involved in oncogenic pathways as 
well as signaling molecules thereby opening 
new avenues in anti-cancer therapy.  
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 A study by Brummelkamp et al. (2002b) 
showed that sequence specific siRNAs can 
inhibit mutant K-Ras gene excluding the wild 
type gene in human pancreatic carcinoma. 
Similarly specific siRNAs have been 
successfully used to target AKt isoforms 2 
and 3 in uterine cancers thereby sensitizing 
the cells to cisplatin (Gagnon et al., 2004).  
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 Cancer associated genes which are not 
mutated but overexpressed in a majority of 
cancers can also be potential target in RNAi 
based techniques. Clusterin is an 
antiapoptotic gene which is expressed in 
most cancers was successfully targeted by 
specific siRNAs which resulted in increased 
chemosensitivity of lung cancer cell lines to 
chemotherapeutic agents (July et al., 2004).  
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